» Articles » PMID: 36476193

Spirulina As a Daily Nutritional Supplement of Young Pre-school Cambodian Children of Deprived Settings: a Single-blinded, Placebo-controlled, Cross-over Trial

Overview
Journal BMC Pediatr
Publisher Biomed Central
Specialty Pediatrics
Date 2022 Dec 8
PMID 36476193
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Spirulina (SP) is widely used as a nutritional supplement to enhance child nutrition in low-income countries. We assessed Spirulina's efficacy of the current dose supplied by institutions in Cambodia on improving growth and anemia in a cross-over randomized controlled trial in preschool underprivileged children from similar settings.

Methods: Preschool children cared by a not-for-profit institution were randomly and blindly allocated (2 to 1) to spirulina or placebo: 100 g in total, given in 2 g per day. After 5 weeks of wash-out, participants were crossed-over to the other group. Anthropometric gain and selected hematological data (blood cell count, ferritin, and C-reactive protein) were assessed at each phase.

Results: A total of 179 children completed the trial, 149 (83.2%) completed all the anthropometrics, and 99 (55.3%) all hematological measures. Mean BMI was 14.18 (95%CI: 14.00-14.37) and 31(20.8%) children had thinness. Mean blood hemoglobin was 11.9 g/dL (95%CI: 11.8-12.1). The weight gain of the SP group showed a modest higher trend compared to placebo (0.63 kg; 95%CI: 0.54-0.72 and 0.46 kg; 95%CI: 0.33-0.58, respectively; p = 0.07). Height increased similarly in both groups. The number of anemic children decreased by 6 (6.06%) and 11 (11.11%) on Placebo or SP, respectively (p = 0.004). Tolerance was good.

Conclusion: SP may be recommended to improve childhood anemia. The analysis of the usual daily dose (2 g) provided by organizations in Cambodia shows a tendency to improve weight gain in the group supplemented with SP very close to significance, but no trend in height. Increased doses and longer supplementation should be evaluated further.

Trial Registration: The study was retrospectively registered at ISRCTN under number 11696165 on 12/12/2018.

References
1.
Karkos P, Leong S, Karkos C, Sivaji N, Assimakopoulos D . Spirulina in clinical practice: evidence-based human applications. Evid Based Complement Alternat Med. 2008; 2011:531053. PMC: 3136577. DOI: 10.1093/ecam/nen058. View

2.
Ku C, Yang Y, Park Y, Lee J . Health benefits of blue-green algae: prevention of cardiovascular disease and nonalcoholic fatty liver disease. J Med Food. 2013; 16(2):103-11. PMC: 3576896. DOI: 10.1089/jmf.2012.2468. View

3.
De M, Halder A, Chakraborty T, Das U, Paul S, De A . Incidence of anemia and effect of nutritional supplementation on women in rural and tribal populations of eastern and northeastern India. Hematology. 2011; 16(3):190-2. DOI: 10.1179/102453311X12953015767455. View

4.
Watanabe F . Vitamin B12 sources and bioavailability. Exp Biol Med (Maywood). 2007; 232(10):1266-74. DOI: 10.3181/0703-MR-67. View

5.
Spolaore P, Joannis-Cassan C, Duran E, Isambert A . Commercial applications of microalgae. J Biosci Bioeng. 2006; 101(2):87-96. DOI: 10.1263/jbb.101.87. View